Search

Author/Creator Mackowiak-Matejczyk, Beata

2. Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2022)

Authors:
Kristeleit, Rebecca; Lisyanskaya, Alla; Fedenko, Alexander; Dvorkin, Mikhail; de Melo, Andreia Cristina; Shparyk, Yaroslav; Rakhmatullina, Irina; Bondarenko, Igor; Colombo, Nicoletta; Svintsitskiy, Valentyn; Biela, Luciano; Nechaeva, Marina; Lorusso, Domenica; Scambia, Giovanni; Cibula, David; Pó...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 4(2022)
Page Start:
465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search